Quidel | QDEL - Gross Profit On Sales


Quidel reported $-91.8M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Agilent USD 990M 44M Mar/2026
Avanos Medical USD 94.2M 8.2M Mar/2026
Becton, Dickinson and Co. USD 2.15B 257M Mar/2026
Bruker USD 379.8M 69.4M Mar/2026
Cerus USD 33.33M 8.66M Dec/2024
Charles River Laboratories USD 279.32M 7.36M Mar/2026
Danaher USD 3.59B 375M Mar/2026
Haemonetics USD 202.39M 7.64M Dec/2025
Illumina USD 721M 38M Mar/2026
IQVIA Holdings USD 1.07B 52M Mar/2026
Merit Medical Systems USD 184.8M 10.56M Mar/2026
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 146.8M 3M Dec/2025
Neogen USD 99M 7.7M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Pacific Biosciences Of California USD 15.74M 601K Dec/2025
Quidel USD -91.8M 366.6M Mar/2026
Revvity USD 387.66M 34M Mar/2026
STAAR Surgical USD 43.74M 34.13M Dec/2025
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Waters USD 542M 15.42M Mar/2026